An internship in summer 2018 under the auspices of UdeM's PREMIER program for excellence in medicine through introduction to research has culminated in the publication of an article in a scientific journal for undergraduate ...
Feb 4, 2022
0
121
(HealthDay)—There has been an age shift in positivity for Chlamydia trachomatis and Neisseria gonorrhoeae among women, according to a study published online Aug. 20 in the American Journal of Preventive Medicine.
Aug 31, 2020
0
2
Trachoma is a disease that can cause blindness and visual impairment in about 1.9 million people every year. Poor communities in rural areas of countries in Africa, Central and South America, Asia, Australia and the Middle ...
Aug 19, 2019
0
2
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries. New research by the University ...
Aug 13, 2019
0
455
Research led by Ashok Aiyar, Ph.D., Associate Professor of Microbiology, Immunology and Parasitology at LSU Health New Orleans School of Medicine, has identified a target that may lead to the development of new treatments ...
May 30, 2019
0
3
When chlamydia attacks the human body, the immune system activates. But the bacteria are adapted to defend themselves. Scientists from Würzburg have deciphered new details of their strategy.
Jun 27, 2018
0
87
A global study of water and sanitation coverage has found that community access to sanitation facilities exceeding 80 percent reduces rates of trachoma, a blinding eye disease caused by repeated infection with Chlamydia trachomatis. ...
Feb 22, 2018
0
9
Exposing the gut to chlamydia protects against subsequent infection in the genital tract and other tissues, researchers from UT Health San Antonio discovered. Chlamydia is the nation's most common sexually transmitted disease ...
Jan 26, 2018
0
9
The presence of specific types of vaginal bacteria may be associated with an increased risk for chlamydia infection, finds a small, but well powered study published online in Sexually Transmitted Infections.
Sep 25, 2017
0
0
Scientists at the Wellcome Trust Sanger Institute and their collaborators at the University of British Columbia have created an innovative technique for studying how chlamydia interacts with the human immune system.
Apr 25, 2017
0
88
Chlamydia trachomatis, an obligate intracellular human pathogen, is one of three bacterial species in the genus Chlamydia. C. trachomatis is Gram-indeterminate (i.e. cannot be stained with the Gram stain); structurally the organism is Gram-negative. Identified in 1907, C. trachomatis was the first chlamydial agent discovered in humans.
C. trachomatis includes three human biovars: trachoma (serovars A, B, Ba or C), urethritis (serovars D-K), and lymphogranuloma venereum (LGV, serovars L1, 2 and 3). Many, but not all, C. trachomatis strains have an extrachromosomal plasmid.
This text uses material from Wikipedia, licensed under CC BY-SA
